US Stock MarketDetailed Quotes
MBIO Mustang Bio
- 0.3033
- -0.0145-4.56%
Trading May 6 13:50 ET
3.80MMarket Cap-50P/E (TTM)
0.3200High0.3000Low122.61KVolume0.3178Open0.3178Pre Close37.88KTurnover1.28%Turnover RatioLossP/E (Static)12.51MShares8.170052wk High30.33P/B2.91MFloat Cap0.220052wk Low--Dividend TTM9.59MShs Float200.2500Historical High--Div YieldTTM6.29%Amplitude0.2200Historical Low0.3080Avg Price1Lot Size
About Mustang Bio Company
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Company Profile
SymbolMBIO
Company NameMustang Bio
Listing DateAug 22, 2017
CEODr. Manuel Litchman, M.D.
MarketNASDAQ
Employees80
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address377 Plantation Street,1st floor
CityWorcester
ProvinceMassachusetts
CountryUnited States of America
Zip Code01605-2245
Phone1-781-652-4500
Websitehttp://www.mustangbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Manuel Litchman, M.D.
- Director, President and Chief Executive Officer
- 656.67K
- James Murphy
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Michael S. Weiss
- Executive Chairman of the Board
- 110.00K
- Dr. Lindsay A. Rosenwald, M.D.
- Director
- 100.00K
- Neil Herskowitz
- Independent Director
- 100.00K
- Adam J. Chill
- Independent Director
- 110.00K
- Dr. Michael J. Zelefsky, M.D.
- Independent Director
- 100.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg